Note: Ingredients listed on restricted chemical lists
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
70-<80
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
<0.2 <0.2
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
<0.1 <0.1
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
20-<30
General Information
Revision date
2018-04-20
Product name
PANADOL FD TABLETS/ CAPLETS
Product Synonyms
PANADOL FD TABLETS (LOCAL) FETTE (ANZ) * PANADOL FD CAPLETS (ANZ) * PANADOL
Emergency telephone
CHEMTREC EMERGENCY NUMBERS
Icons in SDS
Company Information
company name
GlaxoSmithKline Australia Phamaceuticals and Vaccines
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 2 Sensitization, skin Category 1B
Environmental hazards
Hazardous to the aquatic environment, acute Category 3 Hazardous to the aquatic environment, Category 3
Long term hazards
Label elements, including precautionary statements Hazard symbol(s) Exclamation mark
Signal word
Warning
Hazard statements
Harmful if swallowed. Harmful to aquatic life with long lasting effects.
Prevention
Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Avoid release to the environment.
Response
IF SWALLOWED: Call a POISON CENTRE or doctor/physician if you feel unwell. Rinse mouth. Specific treatment (see on this label).
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 for additional information on health hazards.
Additional information
None.
